Compare CVS Health Corp (CVS) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Sirius XM Holdings Inc — how do they compare? CVS Health Corp trades at $107.85 (market cap $135.48B), while Sirius XM Holdings Inc trades at $31.08 (market cap $10.23B). The key difference: CVS Health Corp is far larger — about 13.2× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays the higher dividend (3.55%). Which is the better fit depends on your goals.
| CVS | SIRI | |
|---|---|---|
Market Cap | $135.48B | $10.23B |
Sector | Health | Media |
52-Week High | $106.18 | $30.75 |
52-Week Low | $58.75 | $19.92 |
Enterprise Value | $202.02B | $19.90B |
Dividend Yield | 2.51% | 3.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Sirius XM Holdings (SIRI) trades at $30.67, up 0.82% with strong technical momentum and bullish moving average signals. The company shows improved fundamentals with three consecutive quarterly earnings beats and a return to profitability in 2025 after a challenging 2024. Recent developments include a strategic advertising partnership with YouTube and potential merger discussions with iHeartMedia, driving positive investor sentiment.
The outlook remains positive with analysts maintaining a $31.17 consensus target and 58% buy ratings. Key opportunities include revenue diversification through new partnerships and strong cash flow generation supporting dividends and buybacks. Risks include intense media competition and high debt levels despite recent improvement from 94% to 36% debt-to-asset ratio since 2022.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
